---
title: TolerogenixX
date: 2017-05-26T08:01:06Z
modified: 2026-08-12T08:59:12Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/tolerogenixx/"
type: portfolio
status: publish
excerpt: ""
wpid: 49043
language:
  - English
post_translations:
  - pll_5927e0c3896d2
branchen22:
  - Immunology
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-12T08:59:12Z
tags:
  - English
  - pll_5927e0c3896d2
  - Immunology
  - Pharmaceuticals
---

## Beschreibungstext

TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the immune system’s defences.

## Unternehmenswebsite

https://www.tolerogenixx.com

## Adresse

TolerogenixX GmbH
Im Neuenheimer Feld 162
69120 Heidelberg

## Kontakt

Array

Array

Array